Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company" or "Plus Therapeutics"), a clinical-stage pharmaceutical company developing targeted radiotherapeutics ...

Results of IMNN-101 Proof-of-Concept study demonstrate persistent immunogenicity in trial participants and further validate PlaCCine® technology IMNN-101 induced 2- to 4-fold increase in neutralizing ...

A single regulator for construction is among a raft of measures announced today (26 February) in response to the Grenfell ...

Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company” or "Plus Therapeutics”), a clinical-stage pharmaceutical company ...

Eikon Therapeutics, Inc., a pivotal-stage biotechnology company that integrates advanced engineering with cutting-edge ...

British born actress and singer, Cynthia Erivo, teases new song release, Replay, with an artistic cover photo. Discover full story: ...

Good morning, and welcome to Tarsus Year End 2024 Financial Results Conference Call. As a reminder, this call is being recorded. At this time, I would like to turn the call over to David Nakasone, ...

Monroe Biomedical Research (MBR), a dedicated clinical trial site, is growing its footprint to enhance early-phase clinical ...